Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2003 Sep 25;22(41):6455-7.
doi: 10.1038/sj.onc.1206739.

BRAF mutations in papillary carcinomas of the thyroid

Toshihiko Fukushima  1 , Shinichi Suzuki, Miyuki Mashiko, Tohru Ohtake, Yoshiyuki Endo, Yuji Takebayashi, Koji Sekikawa, Koichi Hagiwara, Seiichi Takenoshita
Affiliations

BRAF mutations in papillary carcinomas of the thyroid

Toshihiko Fukushima et al. Oncogene. .

Abstract

BRAF is a serine/threonine kinase that receives a mitogenic signal from RAS and transmits it to the MAP kinase pathway. Recent studies have reported that mutations of the BRAF gene were detected with varying frequencies in several cancers, notably more than 60% in melanoma. We analysed mutations of BRAF and RAS genes in 100 cases of thyroid carcinoma to investigate genetic aberrations in the RAS/RAF/MEK/MAP kinase pathway. BRAF mutations were detected exclusively in papillary carcinomas (40 in 76 cases: 53%), and were exclusively V599E, a mutation frequently observed in other carcinomas. NRAS mutation was observed in six cases (6%), all in histological types other than papillary carcinoma, and was exclusively Q61R. No mutations were found in KRAS or HRAS. Our results suggest that BRAF mutations may play a critical role in the carcinogenesis of papillary carcinoma of the thyroid.

PubMed Disclaimer